Unknown

Dataset Information

0

Aspalathin, a natural product with the potential to reverse hepatic insulin resistance by improving energy metabolism and mitochondrial respiration.


ABSTRACT: Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its efficacy to moderate complications associated with hepatic insulin resistance is unknown. To study such effects, C3A liver cells exposed to palmitate were used as a model of hepatic insulin resistance. These hepatocytes displayed impaired substrate metabolism, including reduced glucose transport and free fatty acid uptake. These defects included impaired insulin signaling, evident through reduced phosphatidylinositol-4,5-bisphosphate 3-kinase/ protein kinase B (PI3K/AKT) protein expression, and mitochondrial dysfunction, depicted by a lower mitochondrial respiration rate. Aspalathin was able to ameliorate these defects by correcting altered substrate metabolism, improving insulin signaling and mitochondrial bioenergetics. Activation of 5'-adenosine monophosphate-activated protein kinase (AMPK) may be a plausible mechanism by which aspalathin increases hepatic energy expenditure. Overall, these results encourage further studies assessing the potential use of aspalathin as a nutraceutical to improve hepatocellular energy expenditure, and reverse metabolic disease-associated complications.

SUBMITTER: Mazibuko-Mbeje SE 

PROVIDER: S-EPMC6497260 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Aspalathin, a natural product with the potential to reverse hepatic insulin resistance by improving energy metabolism and mitochondrial respiration.

Mazibuko-Mbeje Sithandiwe E SE   Dludla Phiwayinkosi V PV   Johnson Rabia R   Joubert Elizabeth E   Louw Johan J   Ziqubu Khanyisani K   Tiano Luca L   Silvestri Sonia S   Orlando Patrick P   Opoku Andy R AR   Muller Christo J F CJF  

PloS one 20190502 5


Aspalathin is a rooibos flavonoid with established blood glucose lowering properties, however, its efficacy to moderate complications associated with hepatic insulin resistance is unknown. To study such effects, C3A liver cells exposed to palmitate were used as a model of hepatic insulin resistance. These hepatocytes displayed impaired substrate metabolism, including reduced glucose transport and free fatty acid uptake. These defects included impaired insulin signaling, evident through reduced p  ...[more]

Similar Datasets

| S-EPMC3609590 | biostudies-literature
| S-EPMC6387445 | biostudies-literature
2024-03-31 | PXD030350 | Pride
| S-EPMC7470648 | biostudies-literature
| S-EPMC6154319 | biostudies-literature
| S-EPMC8476542 | biostudies-literature
| S-EPMC3971904 | biostudies-literature
| S-EPMC6582130 | biostudies-literature
| S-EPMC7190669 | biostudies-literature
| S-EPMC3135002 | biostudies-literature